Both Melbourne and the biotech industry are set to benefit this October when International BioFest 2016 becomes the focus of global biotechnology.
Hosted at the Melbourne Convention and Exhibition Centre (MCEC), this event will be the largest-ever gathering in Australian life sciences, with three major conferences coming together in one week in one place as one integrated network.
AusBiotech is a national industry organisation comprising of companies and individuals seeking to advance the biotechnology and life science industry in Australia by offering representation and services. AusBiotech is an expansive network of over 3,000 members in the life sciences.
AusBiotech 2016 is its national conference. To have it in Melbourne is a major win for the city, especially considering it will be joined by 17th International Biotechnology Symposium and Exhibition (IBS) and Australia Biotech Invest, making it the largest gathering in the life science sector in our nation’s history.
It will be held at MCEC from the 24-27 October and expects to attract over 2,500 delegates from all over the world.
Club Melbourne Ambassador Dr Anna Lavelle, Chief Executive Officer of AusBiotech, believes the Australian biotech industry is positioned for fast global growth and development.
Australian biotechnology innovation is ranked fourth in the world. Recent months have seen innovation placed firmly on the Australian political agenda and last year the biotechnology industry attracted record deal flows of almost $2 billion and capital raising at $1.1 billion.
“Australia’s life sciences industry is in an unprecedented position to boost Australia’s productivity, economic performance and build our nation’s job and exports, in addition to delivering life-saving and enhancing technologies.”
The benefit to Melbourne if such a growth were to take place would be pronounced as it is a leader in the biotech industry.
A significant number of AusBiotech members will gather at this year’s conference to learn and connect with other people in the industry. They will also be able to hear from renowned key-note speakers. Furthermore, it will strengthen the already established reputation that Melbourne has for being one of the world’s great biotech hubs.
AusBiotech will attract delegates from all facets of the sector’s ecosystem - including focal points in research, industry and investment, making it ideal for anyone involved in the biotech industry.
“AusBiotech is particularly beneficial for early to mid-career researchers who wish to expand their network, especially this year while joined by the International Biotechnology Symposium,” said Dr Lavelle.
IBS 2016 allows Australians, and especially people living in Melbourne, to connect with an international network, which will benefit their careers and develop the biotech industry here in Australia.
Dr Lavelle also notes that the overlap on the conferences would be leveraged for attendees, “while the three conferences are self-contained entities, there will be a number of shared plenaries and events to foster networking and learning opportunities as well as a shared major exhibition and business matching.
International Biofest 2016 is a great opportunity for the biotech industry and for Melbourne. For more information, visit: http://internationalbiofest.org/